Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 377.25M
March 31, 2026 63.63M
December 31, 2025 64.01M
September 30, 2025 -1.254M
June 30, 2025 -2.53M
March 31, 2025 -3.295M
December 31, 2024 -3.34M
September 30, 2024 -11.72M
June 30, 2024 -5.766M
March 31, 2024 -2.533M
December 31, 2023 0.287M
September 30, 2023 4.947M
June 30, 2023 12.00M
March 31, 2023 15.22M
September 30, 2022 33.96M
June 30, 2022 31.17M
March 31, 2022 22.50M
December 31, 2021 18.98M
Date Value
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 -0.5035M
June 30, 2019 -1.038M
March 31, 2019 -1.594M
December 31, 2018 -2.053M
September 30, 2018 -1.756M
June 30, 2018 -1.415M
March 31, 2018 -1.038M
September 30, 2017 -0.5797M
June 30, 2017 -0.3733M
March 31, 2017 -0.1799M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Xencor, Inc. 94.79M
UroGen Pharma Ltd. 171.46M
Ironwood Pharmaceuticals, Inc. 387.48M
Viking Therapeutics, Inc. -0.45M
IDEAYA Biosciences, Inc. 229.62M